More recent studies have identified RBBP9 as a serine hydrolase that promotes cancer progression by inhibiting the anti-proliferative function of transforming growth factor (TGF)-b in a pancreatic cancer model.15 The gene discussed is RBBP9; the disease is pancreatic neoplasm.